Mycosis fungoides and Sezary syndrome: New pathogenetic aspects [Aktuelle aspekte zur pathogenese von Sézary-syndrom und mycosis fungoides]

被引:0
|
作者
Dummer R. [1 ]
Willers J. [1 ]
Döbbeling U. [1 ]
Burg G. [1 ]
机构
[1] Universitätsspital Zürich, Dermatologische Klinik, Zürich
来源
Der Hautarzt | 2001年 / 52卷 / 3期
关键词
Cutaneous T-cell lymphoma; Cytokines; Interferon; Interleukin-15; Mycosis fungoides; Sézary syndrome;
D O I
10.1007/s001050051288
中图分类号
学科分类号
摘要
Cutaneous T-cell lymphomas are a heterogeneous group of lymphoproliferative skin disorders whose pathogenesis is poorly understood. Cytokines and chemokines are important factors which can modify the cutaneous microenvironment allowing the accumulation of lymphocytes. Most of these neoplasms seem to be T helper-2 cells. While interferon gamma is the natural inhibitor of clonal T-cell proliferations, interferon resistance has been recently found in these cells. This interferon resistance may be an Achilles heel that can be targeted by molecular therapeutic interventions.
引用
收藏
页码:189 / 192
页数:3
相关论文
共 50 条
  • [31] Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome
    Zachary A. Corbin
    Annie Nguyen-Lin
    Shufeng Li
    Ziba Rahbar
    Mahkam Tavallaee
    Hannes Vogel
    Katrin A. Salva
    Gary S. Wood
    Youn H. Kim
    Seema Nagpal
    Journal of Neuro-Oncology, 2017, 132 : 439 - 446
  • [32] Angeborene QT-Syndrome und Brugada-Syndrom: Aktuelle Aspekte zur Pathogenese, Diagnostik und Therapie
    Wilhelm Haverkamp
    Herzschrittmachertherapie und Elektrophysiologie, 2002, 13 (3): : 119 - 120
  • [33] Assessing Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome: Unmet Needs
    Brazel, Danielle
    Larocca, Cecilia
    Shinohara, Michi M.
    CANCERS, 2024, 16 (15)
  • [34] Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
    Quadri, Iman
    Reneau, John C.
    Hanel, Walter
    Chung, Catherine G.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Perspectives on and Quality of Life in Skin of Color Patients With Mycosis Fungoides/S?zary Syndrome: A Qualitative Analysis
    Abraham, Jaclyn
    Wei, Grace
    Desai, Seemal R.
    Chen, Pei-Ling
    Seminario-Vidal, Lucia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [36] Increased expression of squamous cell carcinoma antigen 1 and 2 in mycosis fungoides and Sézary syndrome
    Kenta Oka
    Takuya Miyagawa
    Hiraku Suga
    Tomomitsu Miyagaki
    Yuka Mizuno
    Hiroaki Kamijo
    Teruyoshi Hisamoto
    Issei Omori
    Hikari Boki
    Tomonori Oka
    Naomi Takahashi-Shishido
    Makoto Sugaya
    Shinichi Sato
    European Journal of Dermatology, 2022, 32 : 464 - 470
  • [37] Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2
    Alexander Ungewickell
    Aparna Bhaduri
    Eon Rios
    Jason Reuter
    Carolyn S Lee
    Angela Mah
    Ashley Zehnder
    Robert Ohgami
    Shashikant Kulkarni
    Randall Armstrong
    Wen-Kai Weng
    Dita Gratzinger
    Mahkam Tavallaee
    Alain Rook
    Michael Snyder
    Youn Kim
    Paul A Khavari
    Nature Genetics, 2015, 47 : 1056 - 1060
  • [38] Total body-surface area as a new prognostic variable in mycosis fungoides and Sezary syndrome
    Novelli, Silvana
    Garcia-Muret, Pilar
    Mozos, Anna
    Sierra, Jorge
    Briones, Javier
    LEUKEMIA & LYMPHOMA, 2016, 57 (05) : 1060 - 1066
  • [39] What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
    Akilov, Oleg E.
    CELLS, 2023, 12 (18)
  • [40] The Treatment of Advanced-Stage Mycosis Fungoides and Sezary Syndrome: a Hematologist's Point of View
    Giordano, Antonio
    Pagano, Livio
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14